Clinical Trials
11 trialsNCT07493304 2026-05-29
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT07410117 2026-05-27
ROXI-CAT-I
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT06861088 2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3 Recruiting
NCT06528418 2025-03-26
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
ChromX Health
Recruiting
NCT02742623 2023-11-07
COSIMO
Bayer
Completed
NCT02073682 2019-03-06
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
Phase 3 Completed
NCT00320255 2016-08-16
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
Bristol-Myers Squibb
Phase 2 Completed
NCT01559883 2014-08-15
Study on Thrombosis Therapy in German Cancer Patients
LEO Pharma
Completed
NCT00219973 2010-04-28
CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
Rovi Pharmaceuticals Laboratories
Phase 3 Completed